Insights

Strong Market Presence As a pioneer in Indonesia’s pharmaceutical industry with over 187 years of history and a workforce exceeding 10,000 employees, Kimia Farma demonstrates substantial market penetration and brand recognition, providing an established platform for expanding product lines and services.

Strategic Collaborations Kimia Farma’s partnerships with Sinopharm and Group 42 on vaccine development and with Tjitra on digital productivity initiatives suggest openness to technology-driven solutions and joint ventures, opening avenues for innovative pharmaceutical and healthcare solution sales.

Growth & Revenue With annual revenues between $500 million and $1 billion and recent funding of $119 million, Kimia Farma has significant financial capacity to invest in new products, technology upgrades, or distribution channels, making it a promising target for expansion-related sales.

Recognition & Awards Kimia Farma’s recognition such as the AKHLAK Award for integrity and ethics underscores its commitment to quality and compliance, indicating potential needs for premium, compliant healthcare solutions and services to maintain its standards.

Product Launch & Innovation The launch of new pharmaceutical products like Remikaf and ongoing vaccine collaborations showcase an active pipeline, providing opportunities for sales of related manufacturing technologies, quality assurance, and distribution solutions tailored to pharmaceutical innovation.

Similar companies to PT. KIMIA FARMA, TBK

PT. KIMIA FARMA, TBK Tech Stack

PT. KIMIA FARMA, TBK uses 8 technology products and services including jsDelivr, Open Graph, Cloudflare, and more. Explore PT. KIMIA FARMA, TBK's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Open Graph
    Content Management System
  • Cloudflare
    Content Management System
  • Floating UI
    Javascript Libraries
  • Google Maps
    Maps
  • Microsoft
    Miscellaneous
  • Animate.css
    UI Frameworks
  • Facebook
    Widgets

Media & News

PT. KIMIA FARMA, TBK's Email Address Formats

PT. KIMIA FARMA, TBK uses at least 1 format(s):
PT. KIMIA FARMA, TBK Email FormatsExamplePercentage
First.Last@kimiafarma.co.idJohn.Doe@kimiafarma.co.id
70%
First@kimiafarma.co.idJohn@kimiafarma.co.id
23%
First.Middle@kimiafarma.co.idJohn.Michael@kimiafarma.co.id
5%
FirstLast@kimiafarma.co.idJohnDoe@kimiafarma.co.id
2%

Frequently Asked Questions

What is PT. KIMIA FARMA, TBK's official website and social media links?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK's official website is kimiafarma.co.id and has social profiles on LinkedInCrunchbase.

How much revenue does PT. KIMIA FARMA, TBK generate?

Minus sign iconPlus sign icon
As of December 2025, PT. KIMIA FARMA, TBK's annual revenue is estimated to be $5B.

What is PT. KIMIA FARMA, TBK's SIC code NAICS code?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PT. KIMIA FARMA, TBK have currently?

Minus sign iconPlus sign icon
As of December 2025, PT. KIMIA FARMA, TBK has approximately 10K employees across 4 continents, including AsiaEuropeNorth America. Key team members include Chief Portfolio & Business Development Officer: J. K.Head Of Production Department: D. K.Head Of Production Department: R. R.. Explore PT. KIMIA FARMA, TBK's employee directory with LeadIQ.

What industry does PT. KIMIA FARMA, TBK belong to?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK operates in the Pharmaceutical Manufacturing industry.

What technology does PT. KIMIA FARMA, TBK use?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK's tech stack includes jsDelivrOpen GraphCloudflareFloating UIGoogle MapsMicrosoftAnimate.cssFacebook.

What is PT. KIMIA FARMA, TBK's email format?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK's email format typically follows the pattern of First.Last@kimiafarma.co.id. Find more PT. KIMIA FARMA, TBK email formats with LeadIQ.

How much funding has PT. KIMIA FARMA, TBK raised to date?

Minus sign iconPlus sign icon
As of December 2025, PT. KIMIA FARMA, TBK has raised $119M in funding. The last funding round occurred on Nov 13, 2022 for $119M.

When was PT. KIMIA FARMA, TBK founded?

Minus sign iconPlus sign icon
PT. KIMIA FARMA, TBK was founded in 1971.

PT. KIMIA FARMA, TBK

Pharmaceutical ManufacturingJakarta, Indonesia10001+ Employees

Kimia Farma merupakan pioner dalam industri farmasi Indonesia. Cikal bakal perusahaan dapat dirunut balik ke tahun 1917, ketika NV Chemicalien Handle Rathkamp & Co., perusahaan farmasi pertama di Hindia Timur, didirikan. Sejalan dengan kebijakan nasionalisasi eks perusahaan-perusahaan Belanda, pada tahun 1958 pemerintah melebur sejumlah perusahaan farmasi menjadi PNF Bhinneka Kimia Farma. Selanjutnya pada tanggal 16 Agustus 1971 bentuk hukumnya diubah menjadi Perseroan Terbatas, menjadi PT Kimia Farma (Persero). Sejak tanggal 4 Juli 2001 Kimia Farma tercatat sebagai perusahaan publik di Bursa Efek Jakarta dan Bursa Efek Surabaya.

Berbekal tradisi industri yang panjang selama lebih dari 187 tahun dan nama yang identik dengan mutu, hari ini Kimia Farma telah berkembang menjadi sebuah perusahaan pelayanan kesehatan utama di Indonesia yang kian memainkan peranan penting dalam pengembangan dan pembangunan bangsa dan masyarakat.

Section iconCompany Overview

SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1971
Employees
10001+

Section iconFunding & Financials

  • $119M

    PT. KIMIA FARMA, TBK has raised a total of $119M of funding over 1 rounds. Their latest funding round was raised on Nov 13, 2022 in the amount of $119M.

  • $500M$1B

    PT. KIMIA FARMA, TBK's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $119M

    PT. KIMIA FARMA, TBK has raised a total of $119M of funding over 1 rounds. Their latest funding round was raised on Nov 13, 2022 in the amount of $119M.

  • $500M$1B

    PT. KIMIA FARMA, TBK's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.